NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its first quarter revenues rose 4 percent year over year, falling short of the consensus Wall Street estimate.

The company's total revenue for the three months ended March 31 was $84.0 million, compared with $80.9 million in the first quarter of 2016, mainly supported by growing prostate cancer and international test sales. Analysts had predicted revenues of $86.2 million on average.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.